Resources from the same session
Safety and activity of the pan–fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients with advanced urothelial carcinoma
Presenter: Jean-Charles Soria
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Quality of life (QoL) and neurotoxicity in germ-cell cancer survivors (GCCS)
Presenter: Jakob Lauritsen
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Phase 1b dose-finding study of avelumab (anti-PD-L1) + axitinib in treatment-naïve patients with advanced renal cell carcinoma
Presenter: James Larkin
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Pembrolizumab (pembro) as first-line therapy for advanced/unresectable or metastatic urothelial cancer: Preliminary results from the phase 2 KEYNOTE-052 study
Presenter: Arjun Balar
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Large retroperitoneal lymphadenopathy (RPLN) and increased risk of venous thromboembolism (VTE) in patients (pts) with metastatic germ cell tumours (mGCT): a global germ cell cancer group (G3) study
Presenter: Ben Tran
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Invited discussant abstracts 781PD and 782PD
Presenter: Aristotelis Bamias
Session: Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Invited discussant abstracts 777PD, 778PD, 779PD and 780PD
Presenter: Christian Kollmannsberger
Session: Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC)
Presenter: Daniel Petrylak
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
Presenter: Joaquim Bellmunt
Session: Genitourinary tumours, non-prostate
Resources:
Abstract
Immunotherapy will be “THE OPTION” in first and second line urothelial tumors
Presenter: Laurence Albiges
Session: Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.